Which brain tumors are histologically and which are topographically malignant?
Lanksch, W.; Stochdorph, O.
Zeitschrift für Allgemeinmedizin 48(22): 1009-1012
1972
ISSN/ISBN: 0300-8673 PMID: 5073629 Document Number: 45298
Document emailed within 1 workday
Related Documents
Bunyaratavej, K.; Siwanuwatn, R.; Chantra, K.; Khaoroptham, S. 2010: Duration of symptoms in brain tumors: influencing factors and its value in predicting malignant tumors Journal of the Medical Association of Thailand 93(8): 903-910Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A. 1994: Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4) No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
Schiffer, D.; Sales, S.; Soffietti, R. 1991: Lonidamine in malignant brain tumors Seminars in Oncology 18(2 Suppl 4: 38-41
Matsutani, M. 1997: Chemoradiation for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(14): 2042-2048
Stieglmayr, F.S. 1973: Chemotherapy of malignant brain tumors Wiener Medizinische Wochenschrift 123(44): 637-642
Ushio, Y.; Mogami, H. 1987: Chemotherapy of malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3227-3233
Kostron, H. 1987: Therapy of malignant brain tumors Wiener Klinische Wochenschrift 99(11): 366-369
Kochi, M.; Ushio, Y. 1994: Targeting therapy for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 738-742
Ransohoff, J. 1977: Surgical management of malignant brain tumors National Cancer Institute Monograph 46: 145-150
Takeshima, H.; Kuratsu, J.-i. 2003: Evolution of chemotherapy for malignant brain tumors No Shinkei Geka. Neurological Surgery 31(7): 725-734
Eary, J.F.; Mankoff, D.A.; Spence, A.M.; Berger, M.S.; Olshen, A.; Link, J.M.; O'Sullivan, F.; Krohn, K.A. 1999: 2-[C-11]thymidine imaging of malignant brain tumors Cancer Research 59(3): 615-621
Knerich, R.; Butti, G.; Pezzotta, S.; Robustelli della Cuna, G.; Adinolfi, D.; Pavesi, L. 1984: Chemotherapy of malignant brain tumors in childhood Minerva Medica 75(24): 1441-1444
Harik, S.I.; Sutton, C.H. 1979: Putrescine as a biochemical marker of malignant brain tumors Cancer Research 39(12): 5010-5015
Shibui, S. 2005: Resent advances in chemotherapy for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(4): 442-447
Arita, N.; Hiraga, S.; Hayakawa, T. 1991: Histological diagnosis of brain tumors: (16). Malignant lymphoma No Shinkei Geka. Neurological Surgery 19(5): 401-406
Hirschberg, H.; Sørensen, D.R.; Angell-Petersen, E.; Peng, Q.; Tromberg, B.; Sun, C-Ho.; Spetalen, S.; Madsen, S. 2006: Repetitive photodynamic therapy of malignant brain tumors Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 25(1-2): 261-279
Nagai, M.; Arai, T. 1982: Interferon therapy for malignant brain tumors-present and future No Shinkei Geka. Neurological Surgery 10(5): 463-476
Seiler, R.W.; Vassella, F.; Markwalder, H. 1979: Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors Surgical Neurology 11(3): 237-242
Marek, K. 1972: Trial of cytostatic therapy of malignant brain tumors in adults Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 110(1): 27-43
Mierzejewska, E. 1976: Clinical pattern of malignant brain tumors in patients over 50 years of age Neurologia i Neurochirurgia Polska 10(6): 738-742